Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Customs Customs + AT Customs - 2001 (5) TMI AT This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2001 (5) TMI 298 - AT - Customs

Issues:
1. Confiscation of goods under Section 113(d) of the Customs Act, 1962 and imposition of penalty.
2. Lack of definitive statement on the identity of the export product.
3. Alleged contravention of provisions of the Drugs and Cosmetics Act, 1940.
4. Examination of the composition of the export product and its impact on identity.
5. Importance of specific charges for action under Section 113(d) of the Customs Act.

Analysis:

1. The case involved the filing of a shipping bill claiming DEPB for exporting a product declared as '4-(4-Chlorophenyl) - 4 -Hydroxypiperdine.' Various authorities conducted tests during the investigation, with conflicting results on the product's composition. The show cause notice alleged contravention of Section 113(d) of the Customs Act, leading to confiscation of goods and a hefty penalty on the exporter. The key argument raised was the lack of clarity in the prohibition regarding the exported goods, making the order unsustainable.

2. Section 113(d) of the Customs Act was central to the dispute, which pertains to goods attempted for export contrary to any prohibition under the Act or other laws. However, the show cause notice did not specify if the confiscation was due to a violation of the Customs Act or any other law. Both parties agreed that the export contravened the Drugs and Cosmetics Act, 1940, based on the Asstt. Drug Controller's findings.

3. The ambiguity surrounding the product's identity created significant challenges. The product was neither clearly identified as a drug nor a cosmetic, crucial under the Drugs and Cosmetics Act. The lack of a definitive statement on the product's nature hindered the determination of its standard quality, as required by the Act. This ambiguity raised doubts about the validity of the Asstt. Drug Controller's assertion regarding the product's quality.

4. The composition analysis revealed the presence of inorganic silicates in the product, alongside chemicals, indicating a potential alteration in the substance's identity. The impact of adding inorganic silicates on the product's character remained unexplored in the proceedings, necessitating a detailed examination to ascertain if such additions changed the product fundamentally.

5. The judgment emphasized the necessity of specific charges under Section 113(d) of the Customs Act to guide exporters in defending their position. The absence of clear grounds for the confiscation and penalty imposed on the exporter highlighted the challenges faced when allegations lack specificity. The decision to remand the case for further examination underscored the need for a comprehensive assessment based on technical literature and expert opinions to determine the exporters' culpability accurately.

 

 

 

 

Quick Updates:Latest Updates